<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2020-10-07" version="189">
<accession>Q9ULV8</accession>
<accession>Q8N1E5</accession>
<accession>Q9Y5Z2</accession>
<accession>Q9Y5Z3</accession>
<name>CBLC_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase CBL-C</fullName>
<ecNumber evidence="9 11 13">2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>RING finger protein 57</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="16">RING-type E3 ubiquitin transferase CBL-C</fullName>
</alternativeName>
<alternativeName>
<fullName>SH3-binding protein CBL-3</fullName>
</alternativeName>
<alternativeName>
<fullName>SH3-binding protein CBL-C</fullName>
</alternativeName>
<alternativeName>
<fullName>Signal transduction protein CBL-C</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CBLC</name>
<name type="synonym">CBL3</name>
<name type="synonym">RNF57</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Gene" volume="239" first="145" last="154">
<title>Molecular cloning and characterization of a novel cbl-family gene, cbl-c.</title>
<authorList>
<person name="Kim M."/>
<person name="Tezuka T."/>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Hirai M."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="10571044"/>
<dbReference type="DOI" id="10.1016/s0378-1119(99)00356-x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT TYR-405</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="3365" last="3375">
<title>cbl-3: a new mammalian cbl family protein.</title>
<authorList>
<person name="Keane M.M."/>
<person name="Ettenberg S.A."/>
<person name="Nau M.M."/>
<person name="Banerjee P."/>
<person name="Cuello M."/>
<person name="Penninger J."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="10362357"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202753"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANT TYR-405</scope>
<scope>FUNCTION AS EGF SIGNALING NEGATIVE REGULATOR</scope>
<scope>PHOSPHORYLATION BY EGFR (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH CRK AND LYN</scope>
<source>
<tissue>Pancreatic adenocarcinoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="1645" last="1655">
<title>Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation.</title>
<authorList>
<person name="Kim M."/>
<person name="Tezuka T."/>
<person name="Tanaka K."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="14661060"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207298"/>
</citation>
<scope>FUNCTION AS E3 UBIQUITIN-PROTEIN LIGASE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH SRC</scope>
<scope>AUTOUBIQUITINATION</scope>
<scope>MUTAGENESIS OF GLY-276; TYR-341 AND CYS-351</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2008" name="J. Neurosci." volume="28" first="8789" last="8800">
<title>CD2AP and Cbl-3/Cbl-c constitute a critical checkpoint in the regulation of ret signal transduction.</title>
<authorList>
<person name="Tsui C.C."/>
<person name="Pierchala B.A."/>
</authorList>
<dbReference type="PubMed" id="18753381"/>
<dbReference type="DOI" id="10.1523/jneurosci.2738-08.2008"/>
</citation>
<scope>FUNCTION IN RET STABILITY</scope>
<scope>INTERACTION WITH RET</scope>
<scope>MUTAGENESIS OF GLY-276 AND CYS-351</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="23687" last="23698">
<title>The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.</title>
<authorList>
<person name="Ryan P.E."/>
<person name="Sivadasan-Nair N."/>
<person name="Nau M.M."/>
<person name="Nicholas S."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="20525694"/>
<dbReference type="DOI" id="10.1074/jbc.m109.091157"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>DOMAIN</scope>
<scope>INTERACTION WITH UBE2D2 AND UBE2D3</scope>
<scope>PHOSPHORYLATION AT TYR-341</scope>
<scope>MUTAGENESIS OF TYR-341</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E49428" last="E49428">
<title>Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5.</title>
<authorList>
<person name="Ryan P.E."/>
<person name="Kales S.C."/>
<person name="Yadavalli R."/>
<person name="Nau M.M."/>
<person name="Zhang H."/>
<person name="Lipkowitz S."/>
</authorList>
<dbReference type="PubMed" id="23145173"/>
<dbReference type="DOI" id="10.1371/journal.pone.0049428"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOUBIQUITINATION</scope>
<scope>PHOSPHORYLATION AT TYR-341</scope>
<scope>INTERACTION WITH TGFB1I1</scope>
<scope>MUTAGENESIS OF TYR-341; CYS-351 AND CYS-366</scope>
</reference>
<reference key="8">
<citation type="submission" date="2010-10" db="PDB data bank">
<title>Crystal structure of Cbl-c (Cbl-3) TKB domain in complex with EGFR py1069 peptide.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.52 ANGSTROMS) OF 9-323 IN COMPLEX WITH EGFR PEPTIDE</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2012" name="J. Biochem." volume="152" first="487" last="495">
<title>Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.</title>
<authorList>
<person name="Takeshita K."/>
<person name="Tezuka T."/>
<person name="Isozaki Y."/>
<person name="Yamashita E."/>
<person name="Suzuki M."/>
<person name="Kim M."/>
<person name="Yamanashi Y."/>
<person name="Yamamoto T."/>
<person name="Nakagawa A."/>
</authorList>
<dbReference type="PubMed" id="22888118"/>
<dbReference type="DOI" id="10.1093/jb/mvs085"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.52 ANGSTROMS) OF 1-323 IN COMPLEX WITH CALCIUM; SRC AND EGFR PEPTIDES</scope>
<scope>CALCIUM-BINDING</scope>
<scope>INTERACTION WITH EGFR AND SRC</scope>
<scope>MUTAGENESIS OF TYR-244; ARG-264; PRO-265; SER-266; THR-268 AND GLY-276</scope>
</reference>
<comment type="function">
<text evidence="7 9 10 11 13">Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Functionally coupled with the E2 ubiquitin-protein ligases UB2D1, UB2D2 and UB2D3. Regulator of EGFR mediated signal transduction; upon EGF activation, ubiquitinates EGFR. Isoform 1, but not isoform 2, inhibits EGF stimulated MAPK1 activation. Promotes ubiquitination of SRC phosphorylated at 'Tyr-419'. In collaboration with CD2AP may act as regulatory checkpoint for Ret signaling by modulating the rate of RET degradation after ligand activation; CD2AP converts it from an inhibitor to a promoter of RET degradation; the function limits the potency of GDNF on neuronal survival.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="9 11 13">
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
<dbReference type="EC" id="2.3.2.27"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="11">Phosphorylation at Tyr-341 is necessary and sufficient for the activation of E3 activity.</text>
</comment>
<comment type="subunit">
<text evidence="7 9 10 11 12 13 14">Interacts with ubiquitin-conjugating enzyme E2 UBE2D2 and UBE2D3. Isoform 1 interacts with EGFR (tyrosine phosphorylated). Interacts with the SH3 domain proteins LYN and CRK. Interacts (via RING-type zinc finger) with TGFB1I1 (via LIM zinc-binding domain 2); the interaction is direct and enhances the E3 activity. Interacts directly with RET (inactive) and CD2AP; dissociates from RET upon RET activation by GDNF which also increases the interaction with CD2AP suggesting dissociation as CBLC:CD2AP complex. Interacts with SRC; the interaction is enhanced when SRC is phosphorylated at 'Tyr-419'.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2341018">
<id>Q9ULV8</id>
</interactant>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9ULV8-1</id>
<name>1</name>
<name>Long</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9ULV8-2</id>
<name>2</name>
<name>Short</name>
<sequence type="described" ref="VSP_005732"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="7">Ubiquitous.</text>
</comment>
<comment type="domain">
<text evidence="11">EF-hand-like and Sh2-like domains are required for N-terminal inhibition of E3 activity.</text>
</comment>
<comment type="domain">
<text evidence="6 11">The N-terminus is composed of the phosphotyrosine binding (PTB) domain, a short linker region and the RING-type zinc finger. The PTB domain, which is also called TKB (tyrosine kinase binding) domain, is composed of three different subdomains: a four-helix bundle (4H), a calcium-binding EF hand and a divergent SH2 domain.</text>
</comment>
<comment type="domain">
<text evidence="4">The RING-type zinc finger domain mediates binding to an E2 ubiquitin-conjugating enzyme.</text>
</comment>
<comment type="PTM">
<text>Phosphorylated on multiple tyrosine residues by SRC. Isoform 1, but not isoform 2, is phosphorylated on tyrosines by EGFR.</text>
</comment>
<comment type="PTM">
<text evidence="9 11 13">Autoubiquitinated when phosphorylated at Tyr-341, enhanced by SRC; suggesting proteasomal degradation.</text>
</comment>
<comment type="miscellaneous">
<text>This protein has one functional calcium-binding site.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CBLcID194.html"/>
</comment>
<dbReference type="EC" id="2.3.2.27" evidence="9 11 13"/>
<dbReference type="EMBL" id="AB028645">
<property type="protein sequence ID" value="BAA86298.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF117646">
<property type="protein sequence ID" value="AAD34341.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF117647">
<property type="protein sequence ID" value="AAD34342.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC028915">
<property type="protein sequence ID" value="AAH28915.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12643.1">
<molecule id="Q9ULV8-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46109.1">
<molecule id="Q9ULV8-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001124324.1">
<molecule id="Q9ULV8-2"/>
<property type="nucleotide sequence ID" value="NM_001130852.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_036248.3">
<molecule id="Q9ULV8-1"/>
<property type="nucleotide sequence ID" value="NM_012116.3"/>
</dbReference>
<dbReference type="PDB" id="3OP0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="A/B=9-323"/>
</dbReference>
<dbReference type="PDB" id="3VRN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.64"/>
<property type="chains" value="A=1-323"/>
</dbReference>
<dbReference type="PDB" id="3VRO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1-323"/>
</dbReference>
<dbReference type="PDB" id="3VRP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="A=1-323"/>
</dbReference>
<dbReference type="PDB" id="3VRQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="A/B=1-323"/>
</dbReference>
<dbReference type="PDB" id="3VRR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-323"/>
</dbReference>
<dbReference type="PDBsum" id="3OP0"/>
<dbReference type="PDBsum" id="3VRN"/>
<dbReference type="PDBsum" id="3VRO"/>
<dbReference type="PDBsum" id="3VRP"/>
<dbReference type="PDBsum" id="3VRQ"/>
<dbReference type="PDBsum" id="3VRR"/>
<dbReference type="SMR" id="Q9ULV8"/>
<dbReference type="BioGRID" id="117156">
<property type="interactions" value="67"/>
</dbReference>
<dbReference type="IntAct" id="Q9ULV8">
<property type="interactions" value="32"/>
</dbReference>
<dbReference type="MINT" id="Q9ULV8"/>
<dbReference type="STRING" id="9606.ENSP00000270279"/>
<dbReference type="iPTMnet" id="Q9ULV8"/>
<dbReference type="PhosphoSitePlus" id="Q9ULV8"/>
<dbReference type="BioMuta" id="CBLC"/>
<dbReference type="DMDM" id="125987803"/>
<dbReference type="EPD" id="Q9ULV8"/>
<dbReference type="jPOST" id="Q9ULV8"/>
<dbReference type="MassIVE" id="Q9ULV8"/>
<dbReference type="PaxDb" id="Q9ULV8"/>
<dbReference type="PeptideAtlas" id="Q9ULV8"/>
<dbReference type="PRIDE" id="Q9ULV8"/>
<dbReference type="ProteomicsDB" id="85137">
<molecule id="Q9ULV8-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="85138">
<molecule id="Q9ULV8-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="3762">
<property type="antibodies" value="368 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="23624"/>
<dbReference type="Ensembl" id="ENST00000341505">
<molecule id="Q9ULV8-2"/>
<property type="protein sequence ID" value="ENSP00000340250"/>
<property type="gene ID" value="ENSG00000142273"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000647358">
<molecule id="Q9ULV8-1"/>
<property type="protein sequence ID" value="ENSP00000494162"/>
<property type="gene ID" value="ENSG00000142273"/>
</dbReference>
<dbReference type="GeneID" id="23624"/>
<dbReference type="KEGG" id="hsa:23624"/>
<dbReference type="UCSC" id="uc002ozs.4">
<molecule id="Q9ULV8-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="23624"/>
<dbReference type="DisGeNET" id="23624"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000142273.10"/>
<dbReference type="GeneCards" id="CBLC"/>
<dbReference type="HGNC" id="HGNC:15961">
<property type="gene designation" value="CBLC"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000142273">
<property type="expression patterns" value="Tissue enhanced (intestine)"/>
</dbReference>
<dbReference type="MIM" id="608453">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9ULV8"/>
<dbReference type="OpenTargets" id="ENSG00000142273"/>
<dbReference type="PharmGKB" id="PA26117"/>
<dbReference type="eggNOG" id="KOG1785">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000162336"/>
<dbReference type="HOGENOM" id="CLU_013535_2_0_1"/>
<dbReference type="InParanoid" id="Q9ULV8"/>
<dbReference type="KO" id="K22518"/>
<dbReference type="OMA" id="QWAVGYV"/>
<dbReference type="OrthoDB" id="540689at2759"/>
<dbReference type="PhylomeDB" id="Q9ULV8"/>
<dbReference type="TreeFam" id="TF314210"/>
<dbReference type="PathwayCommons" id="Q9ULV8"/>
<dbReference type="SignaLink" id="Q9ULV8"/>
<dbReference type="SIGNOR" id="Q9ULV8"/>
<dbReference type="BioGRID-ORCS" id="23624">
<property type="hits" value="8 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="CBLC"/>
<dbReference type="GenomeRNAi" id="23624"/>
<dbReference type="Pharos" id="Q9ULV8">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9ULV8"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="Q9ULV8">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000142273">
<property type="expression patterns" value="Expressed in mucosa of transverse colon and 94 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9ULV8">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9ULV8">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005154">
<property type="term" value="F:epidermal growth factor receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001784">
<property type="term" value="F:phosphotyrosine residue binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030971">
<property type="term" value="F:receptor tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042059">
<property type="term" value="P:negative regulation of epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007175">
<property type="term" value="P:negative regulation of epidermal growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043407">
<property type="term" value="P:negative regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd09920">
<property type="entry name" value="SH2_Cbl-b_TKB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.930.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00287"/>
<dbReference type="InterPro" id="IPR024162">
<property type="entry name" value="Adaptor_Cbl"/>
</dbReference>
<dbReference type="InterPro" id="IPR014741">
<property type="entry name" value="Adaptor_Cbl_EF_hand-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036537">
<property type="entry name" value="Adaptor_Cbl_N_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR003153">
<property type="entry name" value="Adaptor_Cbl_N_hlx"/>
</dbReference>
<dbReference type="InterPro" id="IPR014742">
<property type="entry name" value="Adaptor_Cbl_SH2-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR024159">
<property type="entry name" value="Cbl_PTB"/>
</dbReference>
<dbReference type="InterPro" id="IPR011992">
<property type="entry name" value="EF-hand-dom_pair"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23007">
<property type="entry name" value="PTHR23007"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02262">
<property type="entry name" value="Cbl_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02761">
<property type="entry name" value="Cbl_N2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02762">
<property type="entry name" value="Cbl_N3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47473">
<property type="entry name" value="SSF47473"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47668">
<property type="entry name" value="SSF47668"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51506">
<property type="entry name" value="CBL_PTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0729">SH3-binding</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="E3 ubiquitin-protein ligase CBL-C" id="PRO_0000055866">
<location>
<begin position="1"/>
<end position="474"/>
</location>
</feature>
<feature type="domain" description="Cbl-PTB" evidence="6">
<location>
<begin position="7"/>
<end position="321"/>
</location>
</feature>
<feature type="calcium-binding region">
<location>
<begin position="199"/>
<end position="210"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="5">
<location>
<begin position="351"/>
<end position="390"/>
</location>
</feature>
<feature type="region of interest" description="4H">
<location>
<begin position="7"/>
<end position="145"/>
</location>
</feature>
<feature type="region of interest" description="EF-hand-like">
<location>
<begin position="146"/>
<end position="218"/>
</location>
</feature>
<feature type="region of interest" description="SH2-like">
<location>
<begin position="219"/>
<end position="321"/>
</location>
</feature>
<feature type="region of interest" description="Linker">
<location>
<begin position="322"/>
<end position="350"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RET" evidence="10">
<location>
<begin position="351"/>
<end position="474"/>
</location>
</feature>
<feature type="binding site" description="Phosphotyrosine">
<location>
<position position="264"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="11 13">
<location>
<position position="341"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_005732" evidence="15">
<location>
<begin position="261"/>
<end position="306"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3208856." id="VAR_018298" evidence="7 8">
<original>H</original>
<variation>Y</variation>
<location>
<position position="405"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with EGFR. Decreases interaction with SRC and abolishes SRC ubiquitination." evidence="12">
<original>Y</original>
<variation>A</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with EGFR and SRC as well as on SRC ubiquitination." evidence="12">
<original>Y</original>
<variation>F</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with EGFR. Decreases interaction with SRC and abolishes SRC ubiquitination." evidence="12">
<original>R</original>
<variation>A</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances interaction with EGFR and SRC as well as SRC ubiquitination." evidence="12">
<original>P</original>
<variation>L</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interactions with EGFR and SRC as well as SRC ubiquitination." evidence="12">
<original>S</original>
<variation>A</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with EGFR. Decreases interaction with and ubiquitination of SRC." evidence="12">
<original>T</original>
<variation>A</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with RET. Binds slightly to SRC, this interaction is independent of SRC phosphorylation. Strongly decreases SRC ubiquitination. Abolishes interaction with EGFR." evidence="9 10 12">
<original>G</original>
<variation>E</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces E3 activity and autoubiquitination. Releases ubiquitin-conjugating enzyme E2 UBE2D2 faster." evidence="9 11 13">
<original>Y</original>
<variation>E</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes activation by EGF stimulation and enhancement by TGFB1I1 of E3 activity." evidence="9 11 13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes E3 activity." evidence="9 11 13">
<location>
<position position="341"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on TGFB1I1 and SRC interactions. Abolishes SRC ubiquitination. Abolishes interaction with TGFB1I1; when associated with A-366. Abolishes interaction with RET and inhibition of RET degradation." evidence="9 10 13">
<original>C</original>
<variation>A</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with TGFB1I1. Abolishes interaction with TGFB1I1; when associated with A-351." evidence="13">
<original>C</original>
<variation>A</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA86298." ref="1" evidence="16">
<original>N</original>
<variation>T</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAH28915." ref="3" evidence="16">
<original>S</original>
<variation>P</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="13"/>
<end position="31"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="40"/>
<end position="42"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="44"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="64"/>
<end position="66"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="76"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="100"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="108"/>
<end position="111"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="116"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="140"/>
<end position="142"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="154"/>
<end position="164"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="168"/>
<end position="171"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="172"/>
<end position="179"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="180"/>
<end position="182"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="189"/>
<end position="198"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="203"/>
<end position="207"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="208"/>
<end position="217"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="224"/>
<end position="232"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="238"/>
<end position="241"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="244"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="252"/>
<end position="254"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="260"/>
<end position="265"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="267"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="273"/>
<end position="278"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="284"/>
<end position="287"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="294"/>
<end position="303"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="320"/>
<end position="323"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OP0"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VRP"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VRQ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00839"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10362357"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10571044"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14661060"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18753381"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20525694"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22888118"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23145173"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source ref="8"/>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10362357"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000305"/>
<sequence length="474" mass="52456" checksum="202634AEDE434544" modified="2007-02-06" version="3">MALAVAPWGRQWEEARALGRAVRMLQRLEEQCVDPRLSVSPPSLRDLLPRTAQLLREVAHSRRAAGGGGPGGPGGSGDFLLIYLANLEAKSRQVAALLPPRGRRSANDELFRAGSRLRRQLAKLAIIFSHMHAELHALFPGGKYCGHMYQLTKAPAHTFWRESCGARCVLPWAEFESLLGTCHPVEPGCTALALRTTIDLTCSGHVSIFEFDVFTRLFQPWPTLLKNWQLLAVNHPGYMAFLTYDEVQERLQACRDKPGSYIFRPSCTRLGQWAIGYVSSDGSILQTIPANKPLSQVLLEGQKDGFYLYPDGKTHNPDLTELGQAEPQQRIHVSEEQLQLYWAMDSTFELCKICAESNKDVKIEPCGHLLCSCCLAAWQHSDSQTCPFCRCEIKGWEAVSIYQFHGQATAEDSGNSSDQEGRELELGQVPLSAPPLPPRPDLPPRKPRNAQPKVRLLKGNSPPAALGPQDPAPA</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

